BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 30956641)

  • 41. Molecular characterization of clinical and environmental
    Karami P; Mohajeri P; Yousefi Mashouf R; Karami M; Yaghoobi MH; Dastan D; Alikhani MY
    Saudi J Biol Sci; 2019 Nov; 26(7):1731-1736. PubMed ID: 31762651
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efflux pump contribution to multidrug resistance in clinical isolates of Pseudomonas aeruginosa.
    Kiser TH; Obritsch MD; Jung R; MacLaren R; Fish DN
    Pharmacotherapy; 2010 Jul; 30(7):632-8. PubMed ID: 20575627
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro and in vivo antibiofilm activity of the synthetic antimicrobial peptide WLBU2 against multiple drug resistant Pseudomonas aeruginosa strains.
    Masihzadeh S; Amin M; Farshadzadeh Z
    BMC Microbiol; 2023 May; 23(1):131. PubMed ID: 37183241
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Overexpressed recombinant quorum quenching lactonase reduces the virulence, motility and biofilm formation of multidrug-resistant Pseudomonas aeruginosa clinical isolates.
    Sakr MM; Aboshanab KM; Elkhatib WF; Yassien MA; Hassouna NA
    Appl Microbiol Biotechnol; 2018 Dec; 102(24):10613-10622. PubMed ID: 30310963
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association of exopolysaccharide genes in biofilm developing antibiotic-resistant Pseudomonas aeruginosa from hospital wastewater.
    Divyashree M; Mani MK; Karunasagar I
    J Water Health; 2022 Jan; 20(1):176-184. PubMed ID: 35100165
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Investigation of Pseudomonas aeruginosa Biofilm Formation and Quorum Sensing Genes in Piperacillin/Tazobactam and Ciprofloxacin Sub-minimal Inhibitory Concentrations].
    Erdal B; Yalınay M; Elmas Ç; Yazıcı GN
    Mikrobiyol Bul; 2020 Oct; 54(4):547-558. PubMed ID: 33107284
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phylogenetic Aspects of Antibiotic Resistance and Biofilm Formation of
    Motevasel M; Haghkhah M; Azimzadeh N
    Can J Infect Dis Med Microbiol; 2024; 2024():6213873. PubMed ID: 38249645
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Virulence factors in multidrug (MDR) and Pan-drug resistant (XDR) Pseudomonas aeruginosa: a cross-sectional study of isolates recovered from ocular infections in a high-incidence setting in southern India.
    Naik P; Pandey S; Gagan S; Biswas S; Joseph J
    J Ophthalmic Inflamm Infect; 2021 Sep; 11(1):36. PubMed ID: 34585284
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Multidrug resistance, biofilm formation, and virulence genes of
    Al-Marri T; Al-Marri A; Al-Zanbaqi R; Ajmi AA; Fayez M
    Vet World; 2021 Nov; 14(11):2869-2877. PubMed ID: 35017833
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical outcomes, molecular epidemiology and resistance mechanisms of multidrug-resistant
    Sid Ahmed MA; Hamid JM; Husain AA; Hadi HA; Skariah S; Sultan AA; Ibrahim EB; Al Khal AL; Soderquist B; Jass J; Omrani AS
    Ann Med; 2021 Dec; 53(1):2345-2353. PubMed ID: 34882052
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Determinants for persistence of Pseudomonas aeruginosa in hospitals: interplay between resistance, virulence and biofilm formation.
    Kaiser SJ; Mutters NT; DeRosa A; Ewers C; Frank U; Günther F
    Eur J Clin Microbiol Infect Dis; 2017 Feb; 36(2):243-253. PubMed ID: 27734161
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Biofilm Formation and Virulence Factors Among Pseudomonas aeruginosa Isolated From Burn Patients.
    Ghanbarzadeh Corehtash Z; Khorshidi A; Firoozeh F; Akbari H; Mahmoudi Aznaveh A
    Jundishapur J Microbiol; 2015 Oct; 8(10):e22345. PubMed ID: 26587205
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of Efflux-Mediated Resistance and Biofilm formation in Virulent
    Akinduti PA; George OW; Ohore HU; Ariyo OE; Popoola ST; Adeleye AI; Akinwande KS; Popoola JO; Rotimi SO; Olufemi FO; Omonhinmin CA; Olasehinde GI
    Antibiotics (Basel); 2023 Mar; 12(3):. PubMed ID: 36978493
    [No Abstract]   [Full Text] [Related]  

  • 54. Phenotypic and Genotypic Characteristics of Biofilm Formation in Clinical Isolates of
    Li Z; Ding Z; Liu Y; Jin X; Xie J; Li T; Zeng Z; Wang Z; Liu J
    Infect Drug Resist; 2021; 14():2613-2624. PubMed ID: 34262306
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of Antibiotic Resistance Genes, Plasmids, Biofilm Formation, and
    Zhou X; Li M; Xu L; Shi C; Shi X
    Microb Drug Resist; 2019 Oct; 25(8):1191-1198. PubMed ID: 31120391
    [No Abstract]   [Full Text] [Related]  

  • 56. Molecular epidemiology, resistance, and virulence properties of Pseudomonas aeruginosa cross-colonization clonal isolates in the non-outbreak setting.
    Hu P; Chen J; Chen Y; Zhou T; Xu X; Pei X
    Infect Genet Evol; 2017 Nov; 55():288-296. PubMed ID: 28911852
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Drug resistance profile and biofilm forming potential of Pseudomonas aeruginosa isolated from contact lenses in Karachi-Pakistan.
    Abidi SH; Sherwani SK; Siddiqui TR; Bashir A; Kazmi SU
    BMC Ophthalmol; 2013 Oct; 13():57. PubMed ID: 24134792
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Coordination of las regulated virulence factors with Multidrug-Resistant and extensively drug-resistant in superbug strains of P. aeruginosa.
    Dehbashi S; Pourmand MR; Alikhani MY; Asl SS; Arabestani MR
    Mol Biol Rep; 2020 Jun; 47(6):4131-4143. PubMed ID: 32474845
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Virulence characteristics of multidrug resistant biofilm forming Acinetobacter baumannii isolated from intensive care unit patients.
    Zeighami H; Valadkhani F; Shapouri R; Samadi E; Haghi F
    BMC Infect Dis; 2019 Jul; 19(1):629. PubMed ID: 31315572
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of nano-silver, nano-copper, deconex and benzalkonium chloride on biofilm formation and expression of transcription regulatory quorum sensing gene (rh1R) in drug-resistance Pseudomonas aeruginosa burn isolates.
    Gholamrezazadeh M; Shakibaie MR; Monirzadeh F; Masoumi S; Hashemizadeh Z
    Burns; 2018 May; 44(3):700-708. PubMed ID: 29290510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.